Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Surg ; 20(1): 309, 2020 Dec 02.
Artigo em Inglês | MEDLINE | ID: mdl-33267809

RESUMO

BACKGROUND: Amyand's hernia is a rare condition approximately 0.4-0.6% of all inguinal hernias. Although rare, the Amyand's hernia is worthy of discussion since the variable presentation that make clinical challenge to diagnose especially in infant. A mesenteric chylous cyst is rare disease and has not been reported in Amyand's hernia. CASE PRESENTATION: We report an unusual case of Type II Amyand's hernia with an enlarging chylous mesenteric cyst on the retrocaecal in the anulus into canalis inguinalis. A-2-months old infant presented with enlarging mass in the right scrotal. During laparotomy exploration, we found inguinal sac with intestinal and appendix content in the sac. In the edge site of the sac we found enlarging of mesenteric cyst on the retrocaecal in the anulus into canalis inguinalis. Based on the histopathology examination, the morphological feature is suitable for mesenteric chylous cyst appearance. CONCLUSION: Presentation of mesenteric chylous cyst is rare, and there was no report about it in Amyand's hernia. This unusual presentation should be considered by the surgeon, especially pediatric surgeon, in Amyand's hernia cases.


Assuntos
Apendicectomia , Hérnia Inguinal/cirurgia , Laparotomia , Cisto Mesentérico/cirurgia , Cistos/diagnóstico , Cistos/diagnóstico por imagem , Células Endoteliais , Hérnia Inguinal/complicações , Hérnia Inguinal/patologia , Humanos , Lactente , Masculino , Cisto Mesentérico/complicações , Cisto Mesentérico/patologia , Resultado do Tratamento
2.
Int J Surg Case Rep ; 116: 109330, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38354576

RESUMO

INTRODUCTION AND IMPORTANCE: Schwannoma's are benign but clinically progressive tumours. Mostly, they present as intradural extramedullary and as a single lesion. They are quite rare in the intramedullary region and multiple lesions. We report a rare case of Multiple Intramedullary Schwannoma in the thoracic region. The aim of this study to inform an uncommon case of intramedullary schwannoma and support an appropriate preoperative diagnostic. CLINICAL PRESENTATION: A 43-year-old female patient was admitted with gradual onset weakness of both lower limbs (4/2) for last two months. Magnetic resonance imaging (MRI) scan disclosed an intramedullary tumour at the thoracal 11th and 12th vertebral levels. It measured 30x20x15 mm and 20x20x12 mm. Complete total resection of multiple lesions was done. Schwanoma's was confirmed based on the histopathological finding. The patient was discharged on 4th day post operative with both leg power 5/5 and needed to medical rehabilitation. Follow-up examination 1 months after surgery revealed favourable, neurological condition (modified McCormick scale: grade I). CLINICAL DISCUSSION: Intramedullary schwannoma is often misdiagnosed as other types of intramedullary tumour. Schwannomas are usually benign and have well defined cleavage plane. Total resection achievable in most cases, offers the best clinical outcome and avoids subsequent recurrence. CONCLUSION: Preoperative diagnosis of intramedullary schwannoma will help establish the optimum medical and surgical treatment and the prognosis. Timely surgery before permanent neurological deficit and gross total resection is recommended to achieve good clinical outcome.

3.
Int J Surg Case Rep ; 104: 107939, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36801762

RESUMO

INTRODUCTION: Meningioma, a primary intracranial neoplasm, accounts for 36 % of all primary brain tumors. Approximately 90 % of cases are benign. Malignant, atypical and anaplastic meningioma potentially have more recurrence risk. In this paper, we report a rapid recurrence of meningioma that is probably the most rapid recurrence for either benign or malignant type. CASE PRESENTATION: This paper reports a case of rapid meningioma recurrence 38 days after the first surgical resection. The histopathological examination showed suspicion of anaplastic meningioma (WHO grade III). The patient has a history of breast cancer. After total surgical resection, there was no recurrence reported until three months, and the patient was planned for radiotherapy. Only several cases have been reported about the recurrence of meningioma. With recurrence the prognosis is poor, and two patients died several days after treatment. The primary treatment for the entire tumor was surgical resection, and several issues were combined with radiotherapy. In this case, the recurrence time from the first surgery was 38 days. The most rapid recurrent meningioma reported to this day was 43 days. CONCLUSION: This case report showed the most rapid onset of recurrent meningioma. Therefore this study cannot show reasons for the rapid onset of recurrence.

4.
BMC Pharmacol Toxicol ; 22(1): 58, 2021 10 12.
Artigo em Inglês | MEDLINE | ID: mdl-34641944

RESUMO

INTRODUCTION: Coronavirus Disease (COVID-19) caused by Novel Coronavirus named as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was declared Pandemic by The World Health Organization (WHO) and a Public Health Emergency of International Concern (PHEIC) on January 30, 2020. Many COVID-19 vaccines have been developed, including CoronaVac vaccines by Sinovac. Health care workers, along with medical clerkship students are the priority to receive the vaccine. However, the Adverse Events Following Immunization (AEFI) of the CoronaVac remains unclear. This study aims to describe and analyze the adverse events following immunization (AEFI) of COVID-19 vaccination in medical students in clerkship programs. METHOD: We conducted a cross-sectional study using a questionnaire to assess AEFI after CoronaVac vaccination among medical clerkship students. A Chi-Square test with 95 % of CI was used to determine whether gender correlated with symptoms of AEFI. RESULT: We identified 144 medical clerkship students. The most common AEFI of SARS-CoV-2 vaccinations was localized pain in the injection site during the first dose with 25 (45 %) reports and the booster dose with 34 (67 %) reports. Then followed by malaise, the first dose with 20 (36 %) reports and the booster dose with 21 (41 %) reports. Other symptoms like headache, fever, shivering, sleepiness, nausea, dysphagia, and cold were also reported. CONCLUSIONS: CoronaVac SARS-COV-2 vaccine has several mild symptoms of AEFI and not correlated with gender. Nevertheless, follow-up after vaccination is needed to prevent immunologic responses that may occur in some patients.


Assuntos
Vacinas contra COVID-19/efeitos adversos , Adulto , Sistemas de Notificação de Reações Adversas a Medicamentos , Apatia , Estágio Clínico , Estudos Transversais , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia , Feminino , Humanos , Imunização Secundária/efeitos adversos , Indonésia , Injeções/efeitos adversos , Masculino , Dor/etiologia , Fatores Sexuais , Estudantes de Medicina , Inquéritos e Questionários , Vacinação/efeitos adversos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA